Tipranavir
1 NDC across 1 manufacturer|0 Generic,1 Brand
Tipranavir is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jun 22, 2005. In 2024, Medicare Part D spent $1 million on Tipranavir across 500 claims for 56 beneficiaries.
Tipranavir is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $16.79 to $16.79 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$16.79 – $16.79
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing TIPRANAVIR
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
APTIVUS 250 MG CAPSULE | $16.7859 per EA | — |
Frequently Asked Questions
What is Tipranavir used to treat?
Tipranavir is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Tipranavir?
In 2024, Medicare Part D spent $1 million on Tipranavir across 500 claims for 56 beneficiaries.
How many Tipranavir products are on the market?
The Tipranavir drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Tipranavir?
NADAC reference prices for Tipranavir range from $16.7859 to $16.7859 per EA.
Which manufacturers make Tipranavir?
1 manufacturer lists Tipranavir in NADAC. Ranked by number of NDCs, the largest are Boehringer Ingelheim Pharmaceuticals Inc. (1).